Patients for Affordable Drugs is soliciting opinions on President Donald Trump’s plan to cut drug costs in the U.S.
The organization says there were several good ideas to come out of Trump’s plan, but that it still fell short from 100 percent.
“We disagree with the President that other countries are ‘freeloading’ when they negotiate lower prices,” the organization said in an email. “America can negotiate with drug corporations too – without hurting patients.”
To take PAD’s poll, click here.